Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any inflammatory bowel disease in which the cause of the disease is a mutation in the TRIM22 gene.
Biomarker and diagnostic research for TRIM22-related inflammatory bowel disease has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for TRIM22-related inflammatory bowel disease.
5 publications have been identified in PubMed for TRIM22-related inflammatory bowel disease. Research spans Review / Meta-Analysis (60%) and Diagnostic / Biomarker (40%).
Zhao Q (2025). [PMID: 40299197](https://pubmed.ncbi.nlm.nih.gov/40299197/). *Stem Cell Rev Rep*. [Review / Meta-Analysis]
Ghosh U (2025). [PMID: 40881087](https://pubmed.ncbi.nlm.nih.gov/40881087/). *World J Clin Pediatr*. [Review / Meta-Analysis]
Hong Z (2025). [PMID: 39915583](https://pubmed.ncbi.nlm.nih.gov/39915583/). *Sci Rep*. [Diagnostic / Biomarker]
Vélez N (2024). [PMID: 39836840](https://pubmed.ncbi.nlm.nih.gov/39836840/). *Biomedica*. [Review / Meta-Analysis]
Wei W (2024). [PMID: 39103474](https://pubmed.ncbi.nlm.nih.gov/39103474/). *Sci Rep*. [Diagnostic / Biomarker]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:56 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about TRIM22-related inflammatory bowel disease